Company Napoca Diab Med S.r.l. with Fiscal Code 21526890
recorded a turnover of 2024 of
81.406,
with a net profit of
53.131
and having an average number of employees of
2.
The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Napoca Diab Med S.r.l.
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
19.715
0
-
0
70.812
44.723
59.722
70.050
95.748
81.406
Total Income - EUR
19.715
0
-
0
70.812
44.723
59.722
70.050
95.748
81.553
Total Expenses - EUR
5.658
0
-
0
15.315
11.785
24.694
23.343
21.172
26.500
Gross Profit/Loss - EUR
14.056
0
-
0
55.497
32.938
35.028
46.707
74.576
55.053
Net Profit/Loss - EUR
13.465
0
-
0
54.609
32.938
34.423
45.676
73.773
53.131
Employees
1
0
-
0
2
2
2
2
2
2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -14.5%, from 95.748 euro in the year 2023, to 81.406 euro in 2024.
The Net Profit decreased by -20.229 euro, from 73.773 euro in 2023, to 53.131 in the last year.
Check the financial reports for the company - Napoca Diab Med S.r.l.
Financial Rating - NAPOCA DIAB MED S.R.L.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Napoca Diab Med S.r.l.
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Napoca Diab Med S.r.l.
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Napoca Diab Med S.r.l.
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Napoca Diab Med S.r.l. - CUI 21526890
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
20.508
20.299
-
19.589
19.210
18.845
18.427
18.485
18.429
18.326
Current Assets
55.600
55.033
-
192
64.506
107.034
173.341
197.513
126.001
119.143
Inventories
0
0
-
0
0
0
0
0
0
0
Receivables
55.542
54.975
-
136
14.150
8.358
24.328
64.695
71.618
11.931
Cash
58
57
-
56
50.356
98.676
149.013
132.817
54.382
107.211
Shareholders Funds
76.107
75.331
-
19.781
74.007
103.192
167.329
213.524
135.027
133.289
Social Capital
45
45
-
43
42
41
40
40
40
40
Debts
0
0
-
0
9.709
22.687
24.439
2.474
9.403
4.541
Income in Advance
0
0
-
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"8622 - 8622"
CAEN Financial Year
8621
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
119.143 euro in 2024 which includes Inventories of
0 euro, Receivables of
11.931 euro and cash availability of
107.211 euro.
The company's Equity was valued at
133.289 euro, while total Liabilities amounted to
4.541 euro.
Equity decreased by -983 euro, from 135.027 euro in 2023, to 133.289 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Napoca Diab Med S.r.l.